KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Non-Current Assets (2017 - 2025)

Historic Non-Current Assets for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to $334.2 million.

  • Twist Bioscience's Non-Current Assets rose 2694.26% to $334.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 billion, marking a year-over-year increase of 580.08%. This contributed to the annual value of $308.9 million for FY2025, which is 1545.45% up from last year.
  • Per Twist Bioscience's latest filing, its Non-Current Assets stood at $334.2 million for Q4 2025, which was up 2694.26% from $308.9 million recorded in Q3 2025.
  • Over the past 5 years, Twist Bioscience's Non-Current Assets peaked at $401.2 million during Q4 2021, and registered a low of $69.3 million during Q1 2021.
  • Moreover, its 5-year median value for Non-Current Assets was $332.6 million (2024), whereas its average is $299.3 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first soared by 51582.39% in 2021, then tumbled by 2426.24% in 2024.
  • Twist Bioscience's Non-Current Assets (Quarter) stood at $401.2 million in 2021, then dropped by 8.24% to $368.1 million in 2022, then decreased by 6.93% to $342.6 million in 2023, then dropped by 23.15% to $263.3 million in 2024, then grew by 26.94% to $334.2 million in 2025.
  • Its last three reported values are $334.2 million in Q4 2025, $308.9 million for Q3 2025, and $303.8 million during Q2 2025.